- Trials with a EudraCT protocol (500)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
500 result(s) found for: Anticoagulant.
Displaying page 1 of 25.
EudraCT Number: 2010-022034-88 | Sponsor Protocol Number: 20101111 | Start Date*: 2010-09-20 | |||||||||||
Sponsor Name:Odense University Hospital | |||||||||||||
Full Title: Evaluation of the optimal dose of prophylactic anticoagulation with low- molecular- weight heparin administered subcutaneously to critically ill patients – part 2 | |||||||||||||
Medical condition: venous thromboembolism | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002204-24 | Sponsor Protocol Number: 1160.203 | Start Date*: 2014-12-17 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: REVERSAL OF ANTICOAGULANT EFFECT OF DABIGATRAN® BY PROTHROMBIN COMPLEX CONCENTRATE (BERIPLEX®) ASSESSED WITH A NOVEL METHOD OF BLOOD LOSS MEASUREMENT | ||
Medical condition: Healthy male volunteers. Study assessing the effect of a single 50IU/Kg dose of Beriplex on the anticoagulant effect of Dabigatran. This is of interest when rapid reversal of its effect is mandate... | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-002529-39 | Sponsor Protocol Number: PHRC2015-07 | Start Date*: 2017-08-30 |
Sponsor Name:CHU Angers | ||
Full Title: Intérêt de l’administration de charbon Activé pour les patients ayant un geste invasif reporté dû à un traitement Anticoagulant Oral Direct | ||
Medical condition: fibrillation auriculaire ou une maladie veineuse thromboembolique | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2007-002630-11 | Sponsor Protocol Number: 1160.64 | Start Date*: 2008-04-07 | |||||||||||
Sponsor Name:Boehringer Ingelheim Pharma GmbH & CoKG | |||||||||||||
Full Title: A phase III randomised, parallel group, double-blind, active controlled study to investigate the efficacy and safety of oral 220 mg dabigatran etexilate (110 mg on the day of surgery followed by 22... | |||||||||||||
Medical condition: Primary VTE prevention in patients following total hip replacement surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) FI (Completed) ES (Completed) BE (Completed) DE (Completed) SE (Completed) DK (Completed) HU (Completed) CZ (Completed) AT (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-000091-24 | Sponsor Protocol Number: TAK-442 202 | Start Date*: 2008-12-02 | |||||||||||
Sponsor Name:Takeda Global Research & Development Centre (Europe) Ltd. | |||||||||||||
Full Title: A Phase 2, Double-blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of TAK-442 in Subjects With Acute Coronary Syndromes | |||||||||||||
Medical condition: acute coronary syndromes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) BE (Completed) DE (Completed) EE (Completed) HU (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-004415-29 | Sponsor Protocol Number: DU176b-PRT007 | Start Date*: 2005-04-18 | |||||||||||
Sponsor Name:Daiichi Medical Research Inc | |||||||||||||
Full Title: A Phase IIa, multi-center, multi-national, open-label, dose ranging study of the efficacy, safety, and tolerability of oral DU-176b administered once or twice daily in the treatment of adult patien... | |||||||||||||
Medical condition: Prophylaxis of venous thromboembolism | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) LV (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-006823-38 | Sponsor Protocol Number: DDOAT2006 | Start Date*: 2007-08-14 |
Sponsor Name:Rheinische Friedrichs-Wilhelms-Universität Bonn | ||
Full Title: D-Dimer guided oral anticoagulation therapy for secondary prevention after venous thrombosis | ||
Medical condition: Female and male patients having suffered from venous thrombosis or pulmonary thromboembolism being treated with oral anticoagulant therapy (OAT) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2012-002263-96 | Sponsor Protocol Number: 39486 | Start Date*: 2012-07-11 |
Sponsor Name:MUMC | ||
Full Title: dabigatran and rivaroxaban: prediction of anticoagulant effect | ||
Medical condition: non valvular atrial fibrillation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-000758-29 | Sponsor Protocol Number: DU-176B PRT011 | Start Date*: 2006-08-18 | |||||||||||
Sponsor Name:Daiichi Sankyo Pharma Development | |||||||||||||
Full Title: A PHASE IIB, RANDOMIZED, PARALLEL GROUP, DOUBLE BLIND, DOUBLE-DUMMY, MULTI-CENTER, MULTI NATIONAL, MULTI-DOSE STUDY OF DU-176b COMPARED TO DALTEPARIN IN PATIENTS UNDERGOING ELECTIVE UNILATERAL TOTA... | |||||||||||||
Medical condition: Prevention of venous thromboembolism (VTE) after total hip replacement | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DK (Completed) LV (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-002138-35 | Sponsor Protocol Number: MEDEA | Start Date*: 2019-11-12 | ||||||||||||||||
Sponsor Name:Amsterdam University Medical Centers - location AMC | ||||||||||||||||||
Full Title: Heavy menstrual bleeding in premenopausal women treated with direct oral anticoagulants - the MEDEA study | ||||||||||||||||||
Medical condition: Heavy menstrual bleeding associated with direct oral anticoagulants in premenopausal women. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: NL (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003342-25 | Sponsor Protocol Number: P170604J | Start Date*: 2018-09-07 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Long-term treatment of cancer associated VTE Optimal dose of apixaban API-CAT STUDY for APIxaban Cancer Associated Thrombosis | |||||||||||||
Medical condition: Patients with breast, prostate, and colorectal active cancer, with objectively documented index event of symptomatic or incidental proximal DVT or symptomatic or incidental PE, after 6 months of an... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Temporarily Halted) PL (Ongoing) ES (Restarted) GB (GB - no longer in EU/EEA) BE (Ongoing) GR (Restarted) AT (Ongoing) NL (Restarted) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-005145-51 | Sponsor Protocol Number: 13-152 | Start Date*: 2015-09-18 |
Sponsor Name:Maastricht University Medical Centre | ||
Full Title: A randomised controlled multicenter trial comparing ultrasound-accelerated catheter-directed thrombolysis, combined with standard anticoagulant therapy, with standard anticoagulant therapy alone, f... | ||
Medical condition: Acute primary iliofemoral deep vein thrombosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2007-007947-28 | Sponsor Protocol Number: EFC10636 | Start Date*: 2008-08-27 | |||||||||||
Sponsor Name:sanofi-aventis recherche & développement | |||||||||||||
Full Title: A Multinational, Multicenter, Randomized, Double-Blind study Comparing the Efficacy and Safety of AVE5026 with placebo for the Extended Prevention of Venous Thromboembolism in Patients Having Under... | |||||||||||||
Medical condition: The subjects who will participate to this clinical trial are patients having undergone hip fracture surgery. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-004911-79 | Sponsor Protocol Number: AR-01 | Start Date*: 2007-10-17 | |||||||||||
Sponsor Name:cliniques Universitaires st luc-ucl | |||||||||||||
Full Title: Pharmacodynamics of Fondaparinux subcutaneous versus continuous intravenous infusion in critically ill patients with or without vasopressors. | |||||||||||||
Medical condition: Thromboprophylaxis to critically ill patients hospitalized in ICU with or without vasopressors | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004199-11 | Sponsor Protocol Number: NOSTRADAMUS | Start Date*: 2007-02-16 | |||||||||||
Sponsor Name:Academic Medical Center | |||||||||||||
Full Title: NOSTRADAMUS: Testing for thrombophilia in patients with a first episode of venous thromboembolism: a randomized controlled trial to assess effects on clinical outcomes, quality of life, and costs. | |||||||||||||
Medical condition: A randomized controlled trial of testing and no testing for thrombophilia in patients with a first episode of venous thrombosis or pulmonary embolism (venous thromboembolism, VTE) will be performed... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-004368-23 | Sponsor Protocol Number: 20121005 | Start Date*: 2012-11-02 | |||||||||||
Sponsor Name:Odense University Hospital | |||||||||||||
Full Title: Feasible strategy for preventing blood clots in critically ill patients with acute kidney Injury | |||||||||||||
Medical condition: venous thromboembolism | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000152-41 | Sponsor Protocol Number: DRI5664 | Start Date*: 2006-04-20 | |||||||||||
Sponsor Name:sanofi-aventis recherche développement | |||||||||||||
Full Title: A multicenter, Randomized, Double Blind, Double Dummy, Parallel Group, Dose Ranging Study of subcutaneous SR123781A with an Enoxaparin calibrator arm in the Prevention of Venous Thromboembolism in ... | |||||||||||||
Medical condition: prevention of VTE in patients undergoing elective total hip replacement surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) FI (Completed) DK (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-000311-13 | Sponsor Protocol Number: RB14.012 | Start Date*: 2014-06-23 | |||||||||||
Sponsor Name:CHRU de Brest | |||||||||||||
Full Title: Prevention of Symptomatic Venous Thromboembolism by Low Molecular Weight Heparin in Hospitalized Medical Patients aged 70 years and older : a Randomized Placebo-Controlled Study | |||||||||||||
Medical condition: Venous Thromboembolism | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-001456-34 | Sponsor Protocol Number: ArgatrobanECMO_1.2 | Start Date*: 2021-07-08 |
Sponsor Name:Medical University of Vienna | ||
Full Title: A prospective randomized pilot trial on safety and feasibility of Argatroban as anticoagulant in patients with extracorporeal membrane oxygenation (ECMO) | ||
Medical condition: patients requiring treatment with extracorporeal membrane oxygenation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-005236-32 | Sponsor Protocol Number: FRAG-A001-401 | Start Date*: 2009-09-23 | |||||||||||
Sponsor Name:Eisai Inc | |||||||||||||
Full Title: Dalteparin Sodium Injection (Fragmin®), Multicenter, Open Label, Single-arm, Long Term (52 weeks) Study for Understanding Safety and Efficacy in Subjects with Malignancies and Symptomatic Venous Th... | |||||||||||||
Medical condition: Venous thromboembolism in patients with malignancies | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) AT (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.